BCM
KIN

BCK Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

BCK Capital Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-145,000
Closed -$1.33M – 159
2021
Q2 		$1.33M Buy
+145,000
New +$843K 0.67% 34

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

BCK Capital Management's KIN Position: Q3 2021 in Review

BCK Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 145,000 shares — an estimated $1.33M sold.

BCK Capital Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $1.33M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • BCK Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • BCK Capital Management sold 145,000 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.33M.
  • BCK Capital Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • BCK Capital Management's Kindred Biosciences, Inc. position peaked at $1.33M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on BCK Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.